Pilsicainide
| CAS No. | 88069-67-4 |
|---|---|
| MDL No. | N/A |
| MF | C17H24N2O |
| MW | 272.40 |
| InChI Key | BCQTVJKBTWGHCX-UHFFFAOYSA-N |
| CAS No. | 88069-67-4 |
|---|---|
| MDL No. | N/A |
| MF | C17H24N2O |
| MW | 272.40 |
| InChI Key | BCQTVJKBTWGHCX-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Pilsicainide is a secondary carboxamide formed by the condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker and antiarrhythmic drug used in Japan for managing atrial tachyarrhythmias. It functions as an anti-arrhythmia drug and sodium channel blocker, and is classified as a secondary carboxamide and organic heterobicyclic compound.
| CAS No. | 88069-67-4 |
|---|---|
| Product Name | Pilsicainide |
| Heavy Atom Count | 20 | Rotatable Bond Count | 3 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 2 | HBD | 1 |
| TPSA | 32.340 Ų | Charge | 0 |
| Exact Mass | 272.18886 | Complexity | 493.47 |
| pKa | 5.875 | XLogP | 3.260 |